In this webinar, Prof. Stephan Stilgenbauer will explore finite therapy in CLL, providing practical guidance on treatment selection and clinical applications. He will highlight the role of targeted therapies versus chemotherapy, strategies for achieving durable disease control, and key considerations when choosing between continuous and fixed-duration approaches.